| Targeting the gut microbiome to control drug pharmacomicrobiomics: The next frontier in oral drug delivery S Kamath, AM Stringer, CA Prestidge, P Joyce Expert Opinion on Drug Delivery 20 (10), 1315-1331, 2023 | 19 | 2023 |
| The impact of common pharmaceutical excipients on the gut microbiota S Subramaniam, S Kamath, A Ariaee, C Prestidge, P Joyce Expert Opinion on Drug Delivery 20 (10), 1297-1314, 2023 | 19 | 2023 |
| Self-emulsifying drug delivery systems (SEDDS) disrupt the gut microbiota and trigger an intestinal inflammatory response in rats S Subramaniam, A Elz, A Wignall, S Kamath, A Ariaee, A Hunter, ... International Journal of Pharmaceutics 648, 123614, 2023 | 18 | 2023 |
| Inulin‐Lipid Core–Shell Microcapsules Target the Gut Microbiota and Mimic the Pharmaceutical Food Effect for Improved Oral Antipsychotic Delivery TR Meola, A Elz, A Wignall, K Paxton, A Hunter, A Ariaee, S Kamath, ... Advanced Functional Materials, 2403914, 2024 | 8 | 2024 |
| The atypical antipsychotics lurasidone and olanzapine exert contrasting effects on the gut microbiome and metabolic function of rats S Kamath, A Hunter, K Collins, A Wignall, P Joyce British Journal of Pharmacology, 2024 | 4* | 2024 |
| Who would be a pharmacist? A national representative cross-sectional survey of pharmacists and students to explore personality traits and associations with job satisfaction and … S Kamath, B Soo, D Mill, J Johnson, AT Page International Journal of Pharmacy Practice 31 (3), 328-336, 2023 | 4 | 2023 |
| A critical need for ‘gut neutrality’: mitigating adverse drug–microbiome interactions S Kamath, P Joyce Expert Opinion on Drug Metabolism & Toxicology, 1-4, 2024 | 2 | 2024 |
| Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC/ISOO framework AM Stringer, BM Hargreaves, RA Mendes, NMA Blijlevens, JS Bruno, ... Supportive Care in Cancer 32 (8), 558, 2024 | 2 | 2024 |
| IUPHAR Themed Review: The Gut Microbiome in Schizophrenia S Kamath, E Sokolenko, K Collins, NSL Chan, N Mills, SR Clark, ... Pharmacological Research, 107561, 2024 | 1 | 2024 |
| Contrasting the pharmacokinetic performance and gut microbiota effects of an amorphous solid dispersion and lipid nanoemulsion for a poorly water-soluble anti-psychotic TR Meola, S Kamath, AS Elz, CA Prestidge, A Wignall, P Joyce European Journal of Pharmaceutics and Biopharmaceutics 203, 114453, 2024 | | 2024 |
| The Oral Bioavailability of Lurasidone is Impacted by Changes to the Gut Microbiome: Implications for Antipsychotic Therapy K Collins, S Kamath, TR Meola, A Wignall, P Joyce bioRxiv, 2024.07. 17.604016, 2024 | | 2024 |
Paul JoyceSenior Research Fellow, University of South Australia在 unisa.edu.au 的电子邮件经过验证
